Scalable Life Sciences ondersteunde het Top Institute Pharma (TI
Pharma) op het terrein van de public
Top Institute Pharma (TI Pharma) is a public-private partnership
in which scientific and business
worlds work together on groundbreaking, multidisciplinary research aimed at improving the development of
socially valuable medicines. The research portfolio is based on the disease areas as specified in Priority
Medicines, a report by the World Health Organization (WHO). The knowledge gained in these projects provides
an important contribution to better, faster and less-expensive development of valuable new medicines.